Illumina Takes a $1.47 Billion Charge Related to Its GRAIL Spinoff

InvestopediaJun 28 11:00 ET

Gene-sequencing Group Illumina Sees $1.47 Bn Q2 Impairment Charge Linked to Grail

Yahoo FinanceJun 28 01:02 ET

Express News | Grail Inc - Estimates That It Will Recognize a Goodwill Impairment Charge in Q2 of 2024 Equal to $888.9 Mln

ReutersJun 27 17:07 ET

Express News | Illumina Inc - Estimates That It Will Recognize an Impairment Charge for Grail Ipr&D Intangible Asset in Q2 of 2024 Equal to $420 Mln

ReutersJun 27 16:44 ET

Express News | Summit Therapeutics Appoints Jeff Huber, Transformational Google and Grail Executive, to Its Board of Directors

ReutersJun 27 16:15 ET

With a valuation of $8 billion, can the dream of Grail (GRAL.US) last after the failure of the Yanmen Pass?

After three years of struggle and tug-of-war, Illumina finally announced the divestiture of Grail on December 17th of last year. And this former unicorn also began its delayed U.S. stock market IPO four years later and officially listed on Nasdaq on June 25th this year, followed by a drama of "nearly 20% drop on the first day" for investors.

Zhitong FinanceJun 26 23:00 ET